BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22927549)

  • 1. Cancer immunoediting by the innate immune system in the absence of adaptive immunity.
    O'Sullivan T; Saddawi-Konefka R; Vermi W; Koebel CM; Arthur C; White JM; Uppaluri R; Andrews DM; Ngiow SF; Teng MW; Smyth MJ; Schreiber RD; Bui JD
    J Exp Med; 2012 Sep; 209(10):1869-82. PubMed ID: 22927549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate IFN-γ-Producing Cells Developing in the Absence of IL-2 Receptor Common γ-Chain.
    Resende M; Cardoso MS; Ribeiro AR; Flórido M; Borges M; Castro AG; Alves NL; Cooper AM; Appelberg R
    J Immunol; 2017 Aug; 199(4):1429-1439. PubMed ID: 28687660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Response to Human Cancer Cells with or without IL-2 Receptor Common γ-Chain Function in NOD Background Mice Lacking Adaptive Immunity.
    Nishime C; Kawai K; Yamamoto T; Katano I; Monnai M; Goda N; Mizushima T; Suemizu H; Nakamura M; Murata M; Suematsu M; Wakui M
    J Immunol; 2015 Aug; 195(4):1883-90. PubMed ID: 26170385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection.
    Barakat FM; McDonald V; Di Santo JP; Korbel DS
    Infect Immun; 2009 Nov; 77(11):5044-9. PubMed ID: 19687195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional alpha beta T cells are sufficient for innate and adaptive immunity against enteric Listeria monocytogenes.
    Bregenholt S; Berche P; Brombacher F; Di Santo JP
    J Immunol; 2001 Feb; 166(3):1871-6. PubMed ID: 11160234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoma IL-12 overexpression facilitates NK cell immunomodulation.
    Rademacher MJ; Cruz A; Faber M; Oldham RAA; Wang D; Medin JA; Schloemer NJ
    Sci Rep; 2021 Apr; 11(1):8321. PubMed ID: 33859303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon is selectively required by dendritic cells for immune rejection of tumors.
    Diamond MS; Kinder M; Matsushita H; Mashayekhi M; Dunn GP; Archambault JM; Lee H; Arthur CD; White JM; Kalinke U; Murphy KM; Schreiber RD
    J Exp Med; 2011 Sep; 208(10):1989-2003. PubMed ID: 21930769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the p60 autolysin enhances NK cell activation and is required for listeria monocytogenes expansion in IFN-gamma-responsive mice.
    Humann J; Bjordahl R; Andreasen K; Lenz LL
    J Immunol; 2007 Feb; 178(4):2407-14. PubMed ID: 17277147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
    Matsushita H; Vesely MD; Koboldt DC; Rickert CG; Uppaluri R; Magrini VJ; Arthur CD; White JM; Chen YS; Shea LK; Hundal J; Wendl MC; Demeter R; Wylie T; Allison JP; Smyth MJ; Old LJ; Mardis ER; Schreiber RD
    Nature; 2012 Feb; 482(7385):400-4. PubMed ID: 22318521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells.
    Choudhry N; Petry F; van Rooijen N; McDonald V
    J Infect Dis; 2012 Jul; 206(1):117-24. PubMed ID: 22517912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
    Luque Y; Cathelin D; Vandermeersch S; Xu X; Sohier J; Placier S; Xu-Dubois YC; Louis K; Hertig A; Bories JC; Vasseur F; Campagne F; Di Santo JP; Vosshenrich C; Rondeau E; Mesnard L
    Kidney Int; 2017 May; 91(5):1146-1158. PubMed ID: 28111009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide.
    Pore D; Mahata N; Chakrabarti MK
    J Biol Chem; 2012 Apr; 287(15):12589-601. PubMed ID: 22343631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.
    Nakata J; Nakano K; Okumura A; Mizutani Y; Kinoshita H; Iwai M; Hasegawa K; Morimoto S; Fujiki F; Tatsumi N; Nakajima H; Nakae Y; Nishida S; Tsuboi A; Oji Y; Oka Y; Sugiyama H; Kumanogoh A; Hosen N
    Leukemia; 2014 Jun; 28(6):1316-25. PubMed ID: 24336127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles for T and NK cells in the innate immune response to Shigella flexneri.
    Le-Barillec K; Magalhaes JG; Corcuff E; Thuizat A; Sansonetti PJ; Phalipon A; Di Santo JP
    J Immunol; 2005 Aug; 175(3):1735-40. PubMed ID: 16034114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
    Mukhopadhyay S; Peiser L; Gordon S
    J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricking the balance: NK cells in anti-cancer immunity.
    Pahl J; Cerwenka A
    Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-α-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells.
    Bao Y; Han Y; Chen Z; Xu S; Cao X
    Eur J Immunol; 2011 Mar; 41(3):657-68. PubMed ID: 21287550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumour-specific antigens underlies cancer immunoediting.
    DuPage M; Mazumdar C; Schmidt LM; Cheung AF; Jacks T
    Nature; 2012 Feb; 482(7385):405-9. PubMed ID: 22318517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.